NADPH P450 oxidoreductase: structure, function, and pathology of diseases
about
A Genetic-Pathophysiological Framework for CraniosynostosisPharmacogenomics of human P450 oxidoreductaseThe regulation of the oxidative phase of the pentose phosphate pathway: new answers to old problemsChronopharmacology: new insights and therapeutic implicationsStructural basis for the electron transfer from an open form of NADPH-cytochrome P450 oxidoreductase to heme oxygenaseCytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMRCYB5D2 requires heme-binding to regulate HeLa cell growth and confer survival from chemotherapeutic agentsComputational Identification of the Paralogs and Orthologs of Human Cytochrome P450 Superfamily and the Implication in Drug DiscoveryGenome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption.Transcriptome changes in rice (Oryza sativa L.) in response to high night temperature stress at the early milky stage.Role of protein-protein interactions in cytochrome P450-mediated drug metabolism and toxicityDetermination of glutamate dehydrogenase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry)Molecular Cloning, Expression Pattern and Polymorphisms of NADPH-Cytochrome P450 Reductase in the Bird Cherry-Oat Aphid Rhopalosiphum padi (L.).Histopathology of melanosis coli and determination of its associated genes by comparative analysis of expression microarraysCorrelation of Cytochrome P450 Oxidoreductase Expression with the Expression of 10 Isoforms of Cytochrome P450 in Human Liver.Identification of a novel putative interaction partner of the nucleoporin ALADIN.Epigenetic regulation of ADME-related genes: focus on drug metabolism and transport.Regulation of Sterol Biosynthesis in the Human Fungal Pathogen Aspergillus fumigatus: Opportunities for Therapeutic DevelopmentCytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review.Membrane Associated Progesterone Receptors: Promiscuous Proteins with Pleiotropic Functions - Focus on Interactions with Cytochromes P450.Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine.Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.NAD+ metabolism: Bioenergetics, signaling and manipulation for therapy.Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase.KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation.Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.Cytochrome b5 plays a dual role in the reaction cycle of cytochrome P450 3A4 during oxidation of the anticancer drug ellipticine.Editorial: Role of Protein-Protein Interactions in Metabolism: Genetics, Structure, Function.Production of 7α,15α-diOH-DHEA from dehydroepiandrosterone by Colletotrichum lini ST-1 through integrating glucose-feeding with multi-step substrate addition strategy.Effect of NADPH-cytochrome P450 reductase on all-trans-retinoic acid efficacy and cytochrome P450 26A1 expression in human myeloid leukaemia HL-60 cells.Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency.Genetic Polymorphisms and In Silico Mutagenesis Analyses of CYP2C9, CYP2D6, and CYPOR Genes in the Pakistani PopulationMicrosecond MD simulations of human CYP2D6 wild-type and five allelic variants reveal mechanistic insights on the functionTriple A patient cells suffering from mitotic defects fail to localize PGRMC1 to mitotic kinetochore fibers
P2860
Q26784240-81528FA0-E84D-4FCF-8AC4-F70A197C3785Q26998463-D460925F-3151-4B7F-94E6-245F3CEA2DADQ27003280-BCF6316F-3420-4061-99F9-4EB6AC94943AQ27022411-BCF836BA-43BB-41F0-9B76-9D03740D64F7Q27681796-2B2C72AE-82FA-4FF4-86B7-D3327550A754Q28271636-7F4A11CB-6C96-4580-996D-2800A90B0AEDQ28539031-061469F1-E12B-4A3A-9373-74F282021793Q28595721-B8A914A0-A009-4588-A972-9EE8A63B59ABQ30303149-DE09DD3C-2E5A-4DF4-B3C5-AFEF5C225896Q30941288-316C1891-5687-4E3F-A6E2-8E92B4139092Q34181972-25AB9E11-C23B-499D-885F-492749ACDE85Q34433610-1DB46167-124D-40A7-9C38-A2A07AFC2A00Q36001940-4B8AEB25-4A07-4F00-8C21-7B9909B79B46Q36089940-DBA2BEDC-0425-4F5F-9046-EE480EB42D76Q37179263-CC31C3CE-C73A-4373-8649-A4F96E608B4AQ37502230-323500BD-4828-4D86-A14E-2FE4267F8124Q37576018-55E3FEF5-0074-4A41-A1FF-0DB94D70088FQ37617395-BFDE1454-037A-44B0-8C4B-C01728B72F4FQ37698004-4AA7DBF8-2180-4985-944B-0BCAC1DDDCD5Q37721257-F226BCEA-1484-4448-8DC0-BD3A8EEAFF60Q38634986-72F9E511-4EFD-47EF-8631-4507B2BF0C26Q38753508-2FA4B433-8092-4163-908A-FC04BE88E829Q38885136-2409945B-635A-4D01-963D-21ED33B71F4BQ41808460-D97E92CD-7193-4C2F-9A39-417EB21A3707Q42107713-FABE04A1-3105-4771-AB5B-72EB823D10B9Q42266862-6490AA03-6928-48D1-91B6-11A209EE69CFQ44457504-4EB33858-F4EC-45DB-A52F-9CE312BE4213Q47096419-2A48A103-A4FD-44A6-8573-54DDDC01F05BQ50860121-99C72FFF-76C4-4742-88C4-ECD33A74CA8DQ51670242-92D845AF-0656-4E5E-8756-86FA9C79F246Q55638445-9782A4AD-DF3C-428A-88D5-91499A9E074CQ58581001-74A1E23E-6692-4DF4-AC07-069B8FB143FDQ58723015-DCE8EE4A-2577-4E51-9AF4-4C040260BF2AQ59136995-3D4AA9E9-0BC5-470B-A047-0D14CFE91EE9
P2860
NADPH P450 oxidoreductase: structure, function, and pathology of diseases
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
NADPH P450 oxidoreductase: structure, function, and pathology of diseases
@ast
NADPH P450 oxidoreductase: structure, function, and pathology of diseases
@en
NADPH P450 oxidoreductase: structure, function, and pathology of diseases
@nl
type
label
NADPH P450 oxidoreductase: structure, function, and pathology of diseases
@ast
NADPH P450 oxidoreductase: structure, function, and pathology of diseases
@en
NADPH P450 oxidoreductase: structure, function, and pathology of diseases
@nl
prefLabel
NADPH P450 oxidoreductase: structure, function, and pathology of diseases
@ast
NADPH P450 oxidoreductase: structure, function, and pathology of diseases
@en
NADPH P450 oxidoreductase: structure, function, and pathology of diseases
@nl
P3181
P1476
NADPH P450 oxidoreductase: structure, function, and pathology of diseases
@en
P2093
Christa E Flück
P304
P3181
P356
10.1016/J.PHARMTHERA.2013.01.010
P407
P577
2013-05-01T00:00:00Z